Publicaciones en las que colabora con MANUEL SÁNCHEZ SANTOS (53)

2024

  1. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs

    British Journal of Pharmacology

2023

  1. Innovación docente en farmacología: relato de nuestra experiencia en el aprendizaje basado en artefactos (ABA)

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 2, pp. 150-163

  2. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 158

  3. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation

    Pharmacological Research, Vol. 198

2022

  1. Herbario virtual online colaborativo en las asignaturas de Farmacognosia y Fitoterapia y Nutraceúticos y Fitoterapia

    La necesidad de la transformación social desde la innovación docente y educativa (Aula Magna), pp. 312-328

  2. Narrativa sanitaria como herramienta docente aplicada para incentivar una comunidad universitaria comprometida con los ODS

    Innovación educativa para el desarrollo sostenible, la economía y la empresa (Aula Magna), pp. 201-218

  3. Novel Horizons in Postbiotics: Lactobacillaceae Extracellular Vesicles and Their Applications in Health and Disease

    Nutrients, Vol. 14, Núm. 24

  4. The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome

    Biomedicine and Pharmacotherapy, Vol. 153

2021

  1. Allium-derived compound propyl propane thiosulfonate (Ptso) attenuates metabolic alterations in mice fed a high-fat diet through its anti-inflammatory and prebiotic properties

    Nutrients, Vol. 13, Núm. 8

  2. Changes in gut microbiota induced by doxycycline influence in vascular function and development of hypertension in doca-salt rats

    Nutrients, Vol. 13, Núm. 9

  3. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729

  4. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity

    Antioxidants, Vol. 10, Núm. 9

  5. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 135

  6. Nuevas tecnologías y apps en el laboratorio de plantas medicinales

    Conference proceedings. CIVINEDU 2021: 5th International Virtual Conference onEducational Research and Innovation

  7. Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation

    Nutrients, Vol. 13, Núm. 8

2020

  1. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects

    British Journal of Pharmacology, Vol. 177, Núm. 9, pp. 2006-2023

  2. Herbario virtual: repaso, práctica, diversión y selfies en la clase de Farmacognosia

    Conference proceedings CIVINEDU 2020: 4th International Virtual Conference on Educational Research and Innovation September 23-24, 2020

  3. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus

    Food & function, Vol. 11, Núm. 6, pp. 5266-5274

  4. Mycophenolate improves brain–gut axis inducing remodeling of gut microbiota in doca-salt hypertensive rats

    Antioxidants, Vol. 9, Núm. 12, pp. 1-18

  5. Opinión de los alumnos universitarios: docencia presencial u online durante la pandemia

    Conference proceedings CIVINEDU 2020: 4th International Virtual Conference on Educational Research and Innovation September 23-24, 2020